Contract award notice
Results of the procurement procedure
Section I: Contracting
entity
I.1) Name and addresses
Royal Brompton and Harefield NHS Foundation Trust
Royal Brompton and Harefield NHS Foundation Trust, Sydney St
South Kensington
SW3 6NP
UK
Contact person: Mr Mas Mohammed
Telephone: +44 207352812184113
E-mail: M.Mohammed2@rbht.nhs.uk
NUTS: UK
Internet address(es)
Main address: http://www.rbht.nhs.uk
Address of the buyer profile: http://www.rbht.nhs.uk
I.4) Type of the contracting authority
Body governed by public law
I.5) Main activity
Health
Section II: Object
II.1) Scope of the procurement
II.1.1) Title
Provision of Autologous Cell Salvage Devices and Consumables
Reference number: DN384761
II.1.2) Main CPV code
33000000
II.1.3) Type of contract
Supplies
II.1.4) Short description
Provision of autologous cell salvage devices and consumables. Tenderers must comply with the UK Medical Devices Directive.
Contract awarded for 3 years with the option to extend for a further 2x12 months period.
II.1.6) Information about lots
This contract is divided into lots:
No
II.1.7) Total value of the procurement
Lowest offer:
400 000.00
GBP/ Highest offer:
400 000.00
GBP
II.2) Description
II.2.3) Place of performance
NUTS code:
UK
UKI
II.2.4) Description of the procurement
The Royal Brompton and Harefield NHS Foundation Trust — our 2 hospitals – (Royal Brompton and Harefield) have prestigious histories as independent institutions specialising in the treatment and diagnosis of heart and lung conditions. Excelling in specialist patient care since 1843, more than 2 500 people work across both sites and each member of the team is dedicated to providing specialist, cutting-edge care. Alongside day-to-day care, our specialists conduct invaluable research. Fromthis, we publish findings and make evidence-based decisions to ensure we’re offering the best care to today’s patients and future generations.
The Trusts is sought a reliable, cost effective and value for money for the provision of autologous cell salvage devices and consumables.
II.2.5) Award criteria
Quality criterion: Quality, clinical acceptance and compatibility with specification
/ Weighting: 75 %
Price
/ Weighting:
25 %
II.2.11) Information about options
Options:
No
II.2.13) Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds:
No
Section IV: Procedure
IV.1) Description
IV.1.1) Type of procedure
Open procedure
IV.1.8) Information about Government Procurement Agreement (GPA)
The procurement is covered by the Government Procurement Agreement:
Yes
Section V: Award of contract
Contract No: DN384761
Title: Provision of Autologous Cell Salvage Devices and Consumables
A contract/lot is awarded:
Yes
V.2 Award of contract
V.2.1) Date of conclusion of the contract
14/05/2019
V.2.2) Information about tenders
Number of tenders received: 3
Number of tenders received by electronic means: 3
The contract has been awarded to a group of economic operators:
No
V.2.3) Name and address of the contractor
LivaNova UK Ltd
1370 Montpellier Court Gloucester Business Park
Gloucester
UK
NUTS: UK
The contractor is an SME:
No
V.2.4) Information on value of the contract/lot (excluding VAT)
Initial estimated total value of the contract/lot:
Total value of the contract/lot:
: 400 000.00
GBP
V.2.5) Information about subcontracting
Section VI: Complementary information
VI.4) Procedures for review
VI.4.1) Review body
Royal Brompton and Harefield NHS Foundation Trust
London
UK
VI.5) Date of dispatch of this notice
31/05/2019